Providing Quality HIV Care

Pregnancy, Childbirth, and HIV

The Latest

Promo Image

This Week in HIV Research: This Is Your Brain on Stigma

The impact of stigma on cognitive performance; risk factor dissonance among young black MSM; pregnancy and the HIV care continuum; new data on pediatric raltegravir use.

Promo Image

This Week in HIV Research: Transgender Women in the Spotlight

Black transgender women and the HIV care continuum; PrEP uptake potential among trans women; an update on U.S. mother-to-child HIV transmission; is extra measles vaccination necessary?

Why U=U Does Not Cover Breastfeeding Img

Why U=U Does Not Cover Breastfeeding

"Undetectable equal untransmittable" is sometimes wrongly interpreted as covering all ways that HIV can be transmitted.

Julia Dettinger, M.P.H.

PrEP Is Safe for Pregnant Women Who Want the HIV Prevention Drug, a New Study Finds

Pre-exposure prophylaxis (PrEP) is safe for pregnant women to use, according to new research presented at the HIV Research for Prevention (HIVR4P2018) conference in Madrid, Spain.

Promo Image

This Week in HIV Research: The Case for Pre-Pregnancy Treatment

The benefits of pre-pregnancy HIV treatment initiation for mothers-to-be; HIV diagnoses rise among young U.S. MSM; cost effectiveness of PrEP for heterosexual women; methotrexate and arterial function.

Pregnant woman with pill bottle

Making Clinical Trials of PrEP More Inclusive of Women, No Matter Their Pregnancy Status

Three new trials of HIV prevention drugs seek to answer directly a question that researchers inside and outside the field of HIV have explicitly avoided for years: How do drugs work -- and are they safe -- in pregnant and breastfeeding women?

Promo Image
News Analysis

This Week in HIV Research: How Antiretrovirals May Affect Birth

The effect of specific regimens on some birth-related events; obstacles to PrEP among U.S. women; improving mortality and treatment success for HIV-positive people who inject drugs; kidney disease and “old” tenofovir.

Lynne Mofenson, M.D., at AIDS 2018 in Amsterdam, the Netherlands (Credit: Terri Wilder)

Lynne Mofenson, M.D., Explains the Dolutegravir Risks for People With HIV Who Want to Get Pregnant

New information was presented at the 2018 International AIDS Conference in Amsterdam about babies born with neural tube defects to women with HIV who started a regimen with dolutegravir (Tivicay, DTG) and then later got pregnant.

breastfeeding line art

To Breastfeed or Not to Breastfeed While Living With HIV? Data Needed!

The risk of transmitting HIV through the breastmilk of virally suppressed women in high-income countries is not known.

Dolutegravir Preconception Signal: Time Is Up for Shoddy Surveillance Img

Dolutegravir Preconception Signal: Time Is Up for Shoddy Surveillance

"It is hard to imagine how in 2018 we could be in this situation where women with HIV are being so woefully underserved," Polly Clayden writes.